Because studies have suggested the pivotal roles of Cdk5 in the pathogenesis of AD (Leclerc et al., 2001), we evaluated the activity of p25, an activator of Cdk5, in the brains of 9-month-old APP/PS1 Tg mice, an AD experimental model (n = 6). The gene discussed is CDK5; the disease is Alzheimer disease.